19 June 2013
Keywords: EMA, CHMP, Osteoporosis, Calcitonin, Long-term use, Nasal spray
Article | 22 July 2012
The European Medicines Agency said on Friday that its Committee for Medicinal Products for Human Use (CHMP) has recommended that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 July 2012
24 July 2012
18 June 2013
© 2013 thepharmaletter.com